RxE2
PrivateLast Round
Seed
Oct 20, 2022
Total Funding Raised
$4M
Momentum Score
25 /100
Company Overview
RxE2 is a healthcare technology company that provides a platform to integrate community pharmacists into clinical trials to enhance patient recruitment, adherence, and data quality.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Healthcare Analytics, Medical AI, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Marketplace Commission
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RxE2 Comps
Public and private peers based on sector, stage, and business model.
RxE2 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 20, 2022 |
Key People
Founding team and executive leadership
RxE2 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| O'Leary Ventures | Seed |
| Badlands Capital | Seed |
| MATTER | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 17, 2026
Launched the "Pharm-to-Trial" model utilizing local pharmacies.
- Oct 10, 2025
Will be attending the NCPA 2025 event.
RxE2 Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RxE2's valuation, stock price, and market status.
